Of rashes and regulatory burdens

Published May 1, 2025 11:37pm ET



I went to the doctor last month, and he told me about a new medication that helps people like me who occasionally have red, rashy skin on their faces. Sorry if this is too much information, but I promise you that the worst is over. 

The new medication is actually an old medication, but with a new application. It’s a version of an acne treatment, but at a very low dose. In other words, it’s already been through the battery of trials and investigations medications must overcome before you can put them in your mouth (or wherever). In this case, the prescribed dose is so much lower that you would think getting it would be easy.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.